K-Line Chart, actual market data is subject to the trading page.
Key Data
Prev. Open
$524.20
Prev. Close
$528.71
Prev. Day's Range
$521.77 - $534.73
52W Range
$401.89 - $642.71
Trading Volume
883.89K
MC
$195.863B
P/E Ratio
29.0x
EPS
$18.18
Company Overview
NYSE
Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry (including in the biotechnology and pharmaceutical sectors). Based in Waltham, Massachusetts, Thermo Fisher was created in 2006 by the merger of Thermo Electron and Fisher Scientific, to form a company with US$ 9 billion in combined revenues.
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
Headquarters168 THIRD AVENUE, WALTHAM, MA, UNITED STATES, 02451
Thermo Fisher Scientific is a global leader in science services, offering instruments, reagents, software, and other solutions to support scientific research, manufacturing, and diagnostics. Its operations span the life sciences, healthcare, and industrial sectors, with significant roles in biopharma and laboratory analysis markets.
Thermo Fisher Scientific operates in the healthcare sector and is classified within the life sciences tools and services industry. Its offerings are critical in laboratory research, biotechnology development, and clinical diagnostics.
Thermo Fisher's revenue is driven by its diverse portfolio, including laboratory instruments, diagnostic products, and biopharmaceutical manufacturing services. Demand for innovative healthcare solutions, advancements in drug development, and diagnostic testing contribute to its growth.
No, Thermo Fisher Scientific does not currently pay dividends. Instead, the company tends to reinvest earnings into research and development, acquisitions, and other strategic growth initiatives to expand its global operations.
Thermo Fisher faces competition from companies like Danaher Corporation, Agilent Technologies, and PerkinElmer. These firms also operate in the life sciences tools and analytical instruments markets, serving similar research and healthcare industries.
Key risks include exposure to economic downturns, potential challenges with integrating acquisitions, and competition in the life sciences and diagnostic industries. Regulatory changes and fluctuations in research funding can also present risks to the company’s operations.
Thermo Fisher invests in innovation, acquisitions, and market expansion, positioning itself as a leader in life sciences and diagnostics. Its strong track record of earnings growth and diversified revenue streams have historically driven shareholder value, though past performance does not guarantee future returns.
Thermo Fisher is well-positioned to benefit from trends like increased biopharma R&D spending, growth in personalized medicine, and global demand for diagnostics. However, maintaining competitive leadership in a fast-paced innovation environment is crucial to capitalizing on these opportunities.
Risk Warning
1.Stock prices may fluctuate significantly; invest with caution. Past performance is not indicative of future results.
2.Digital asset trading involves multiple risks, including market and technical risks. Please make rational decisions and allocate assets wisely.
3.The information contained on this page is for reference only and does not constitute any investment advice.
